;
Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Actavis, Apotex, Dr. Reddy's, Mylan, Orchid Chemicals & Pharmaceuticals, Roche musculoskeletal news

    Actavis plc (NYSE:ACT), Dublin, Ireland Apotex Inc., Toronto, Ontario Dr. Reddy's Laboratories Ltd. (NYSE:RDY), Hyderabad, India Mylan Inc. (NASDAQ:MYL), Canonsburg, Pa. Orchid Chemicals & Pharmaceuticals Ltd. (BSE:…

    Published on 4/21/2014
  • Astellas, U.S. Department of Justice infectious news

    Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan U.S. Department of Justice, Washington, D.C. Business: Infectious Astellas will pay $7.3 million to the U.S. Department of Justice to resolve civil claims alleging off-…

    Published on 4/21/2014
  • Delaware State Senate biosimilars news

    Delaware State Senate, Dover, Del. Business: Biosimilars The Delaware State Senate passed a bill that authorizes pharmacists to substitute an FDA-approved interchangeable biosimilar for a prescribed biological product. …

    Published on 4/21/2014
  • Federal Joint Committee (G-BA) pharmaceuticals news

    Federal Joint Committee (G-BA), Berlin, Germany Business: Pharmaceuticals G-BA formally ended assessments of drugs that were launched before January 2011, when drug pricing law AMNOG came into effect. The move comes …

    Published on 4/21/2014
  • Genentech, Novartis, Roche ophthalmic news

    Genentech Inc., South San Francisco, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Ophthalmic Roche and Novartis confirmed French authorities …

    Published on 4/21/2014
  • J&J, Scripps Research Institute other news

    Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. The Scripps Research Institute, La Jolla, Calif. Business: Other The institute launched Scripps Advance to identify and invest in early stage biomedical research …

    Published on 4/21/2014
  • Knight Therapeutics, Medicure cardiovascular news

    Knight Therapeutics Inc. (TSX-V:GUD), Westmount, Quebec Medicure Inc. (TSX-V:MPH; Pink:MCUJF), Winnipeg, Manitoba Business: Cardiovascular Medicure hired Knight as an advisor to advance the company's U.S. specialty …

    Published on 4/21/2014
  • Lytix, Pharmasum Therapeutics neurology news

    Lytix Biopharma A/S, Tromso, Norway Pharmasum Therapeutics A/S, Tromso, Norway Business: Neurology Infectious disease and cancer company Lytix spun out Pharmasum to develop PST-900, a dual-specificity tyrosine-(Y)-…

    Published on 4/21/2014
  • Novartis chemistry, pharmaceuticals news

    Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Chemistry, Pharmaceuticals Novartis said it will "significantly reduce" its internal discovery efforts in RNA therapeutics due to "ongoing challenges with …

    Published on 4/21/2014
  • Pfizer, Teva autoimmune, neurology, generics news

    Pfizer Inc. (NYSE:PFE), New York, N.Y. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Autoimmune, Neurology, Generics Teva received rights to launch a generic version of Pfizer's Celebrex…

    Published on 4/21/2014
  • Qiagen diagnostic news

    Qiagen N.V. (Xetra:QIA; NASDAQ:QGEN), Venlo, the Netherlands Business: Diagnostic Qiagen said it will close its site in Gaithersburg, Md., by early 2015 and move activities to its facilities in Germantown, Md. The …

    Published on 4/21/2014
  • Roslin Cells, Cell Therapy Catapult, Irish Blood Transfusion Service, Loughborough University, NHS Blood and Transplant (NHSBT), Scottish National Blood Transfusion Service (SNBTS), University of ...

    Roslin Cells Ltd., Edinburgh, U.K. Cell Therapy Catapult, London, U.K. Irish Blood Transfusion Service, Dublin, Ireland Loughborough University, Leicestershire, U.K. NHS Blood and Transplant (NHSBT), Hertfordshire, U.K.…

    Published on 4/21/2014
  • UnitedHealth Group Inc. infectious news

    UnitedHealth Group Inc. (NYSE:UNH), Minneapolis, Minn. Business: Infectious On a conference call to discuss the company's 1Q14 earnings, UnitedHealth CFO Dan Schumacher said the insurer recorded a little more than $100 …

    Published on 4/21/2014
  • Xenetic hematology news

    Xenetic Biosciences Inc. (OTCBB:XBIO), Lexington, Mass. Business: Hematology In 1Q14, U.K.-based Xenetic Biosciences plc became U.S.-based Xenetic Biosciences Inc. In January, Xenetic Biosciences plc delisted from LSE …

    Published on 4/21/2014
  • Zogenix neurology news

    Zogenix Inc. (NASDAQ:ZGNX), San Diego, Calif. Business: Neurology A judge in the U.S. District Court for the District of Massachusetts granted Zogenix's motion for a preliminary injunction thus stopping Massachusetts' …

    Published on 4/21/2014
  • Alkermes, Zogenix neurology news

    Alkermes plc (NASDAQ:ALKS), Dublin, Ireland Zogenix Inc. (NASDAQ:ZGNX), San Diego, Calif. Business: Neurology Zogenix filed suit challenging Massachusetts Gov. Deval Patrick's executive order banning the prescription or…

    Published on 4/14/2014
  • Alnylam chemistry news

    Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), Cambridge, Mass. Business: Chemistry Alnylam said the European Patent Office upheld European Patent No. EP 1423406 in oral opposition proceedings. The '406 patent is part of …

    Published on 4/14/2014
  • Astellas gene/cell therapy news

    Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Gene/Cell therapy Astellas established a regenerative medicines unit to specialize in the discovery and R&D of regenerative medicines and cell therapies. …

    Published on 4/14/2014
  • Bayer, Natco cancer, generics news

    Bayer AG (Xetra:BAYN), Leverkusen, Germany Natco Pharma Ltd. (BSE:NATCO; NSE:NATCOPHARM), Hyderabad, India Business: Cancer, Generics On March 26, the Delhi High Court barred Natco from exporting a generic version of …

    Published on 4/14/2014
  • Biocon, Novartis endocrine/metabolic news

    Biocon Ltd. (NSE:BIOCON; BSE:BIOCON), Bangalore, India Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Endocrine/Metabolic On March 27, Novartis filed a suit in the High Court of Delhi seeking an …

    Published on 4/14/2014
  • Biota Pharmaceuticals, Gilead, Chugai, GlaxoSmithKline, Roche infectious news

    Biota Pharmaceuticals Inc. (NASDAQ:BOTA), Alpharetta, Ga. Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London…

    Published on 4/14/2014
  • Capillary Film Technology diagnostic news

    Capillary Film Technology Ltd., West Sussex, U.K Business: Diagnostic Capillary Film Technology received a 98,000 ($162,366) Small Business Innovation Research (SBIR) from NHS England to develop a point-of-care …

    Published on 4/14/2014
  • Compugen cancer news

    Compugen Ltd. (NASDAQ:CGEN; Tel Aviv:CGEN), Tel Aviv, Israel Business: Cancer In response to Israeli news reports that the husband of Compugen CFO Dikla Axselbrad is being investigated for alleged insider trading, …

    Published on 4/14/2014
  • Eli Lilly, Takeda endocrine/metabolic news

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Takeda Pharmaceutical Co. Ltd. (Tokyo:4502), Osaka, Japan Business: Endocrine/Metabolic A jury in the U.S. District Court for the Western District of Louisiana, ordered …

    Published on 4/14/2014
  • Eli Lilly, Unitio endocrine/metabolic news

    Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Unitio, Boston, Mass. Business: Endocrine/Metabolic Eli Lilly partnered with the non-profit's T1D Exchange to use real-world, patient-centric data to identify ways to …

    Published on 4/14/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993